» Articles » PMID: 30100396

Glucose and Insulin-Related Traits, Type 2 Diabetes and Risk of Schizophrenia: A Mendelian Randomization Study

Overview
Journal EBioMedicine
Date 2018 Aug 14
PMID 30100396
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The link between schizophrenia and diabetes mellitus is well established by observational studies; however, the cause-effect relationship remains unclear.

Methods: Here, we conducted Mendelian randomization analyses to assess a causal relationship of the genetic variants related to elevated fasting glucose levels, hemoglobin A (HbA), fasting insulin levels, and type 2 diabetes with the risk of schizophrenia. The analyses were performed using summary statistics obtained for the variants identified from the genome-wide association meta-analyses of fasting glucose levels (up to 133,010 individuals), HbA (up to 153,377 individuals), fasting insulin levels (up to 108,557 individuals), type 2 diabetes (up to 659,316 individuals), and schizophrenia (up to 108,341 individuals). The association between each variant and schizophrenia was weighted by its association with each studied condition, and estimates were combined using an inverse-variance weighted meta-analysis.

Findings: Using information from thirteen variants related to fasting insulin levels, the causal effect of fasting insulin levels increases (per 1-SD) on the risk of schizophrenia was estimated at an odds ratio (OR) of 2·33 (p = 0·001), which is consistent with findings from the observational studies. The fasting glucose associated single nucleotide polymorphisms (SNPs) had no effect on the risk of schizophrenia in Europeans and East Asians (p > 0·05). Nonsignificant effects on the risk of schizophrenia was observed with raised HbA and type 2 diabetes, and consistent estimates were obtained across different populations.

Interpretation: Our results suggest a causal role of elevated fasting insulin levels in schizophrenia pathogenesis.

Citing Articles

Autophagy Associated Genes (ARGs) -Based Predictive Model AIDPS for Prostate Cancer.

Zhao Z, Yang Y, Sun Z, Fan L, Liu L J Cell Mol Med. 2025; 29(1):e70213.

PMID: 39789383 PMC: 11717666. DOI: 10.1111/jcmm.70213.


A network of transcriptomic signatures identifies novel comorbidity mechanisms between schizophrenia and somatic disorders.

Zhang Y, Bharadhwaj V, Kodamullil A, Herrmann C Discov Ment Health. 2024; 4(1):11.

PMID: 38573526 PMC: 10994898. DOI: 10.1007/s44192-024-00063-8.


Genomic insights into the comorbidity between type 2 diabetes and schizophrenia.

Arruda A, Khandaker G, Morris A, Davey Smith G, Huckins L, Zeggini E Schizophrenia (Heidelb). 2024; 10(1):22.

PMID: 38383672 PMC: 10881980. DOI: 10.1038/s41537-024-00445-5.


regulates PTP61F, affecting insulin signaling, metabolic homeostasis, and starvation resistance in .

Saedi H, Waro G, Giacchetta L, Tsunoda S Proc Natl Acad Sci U S A. 2024; 121(5):e2319475121.

PMID: 38252824 PMC: 10835047. DOI: 10.1073/pnas.2319475121.


Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures.

Lee J, Xue X, Au E, McIntyre W, Asgariroozbehani R, Panganiban K Transl Psychiatry. 2024; 14(1):19.

PMID: 38199991 PMC: 10781725. DOI: 10.1038/s41398-023-02716-8.


References
1.
Torrey E, Bartko J, Yolken R . Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012; 38(3):642-7. PMC: 3329973. DOI: 10.1093/schbul/sbs043. View

2.
Ryan M, Thakore J . Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002; 71(3):239-57. DOI: 10.1016/s0024-3205(02)01646-6. View

3.
de Candia T, Lee S, Yang J, Browning B, Gejman P, Levinson D . Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. Am J Hum Genet. 2013; 93(3):463-70. PMC: 3845872. DOI: 10.1016/j.ajhg.2013.07.007. View

4.
Davey Smith G, Hemani G . Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89-98. PMC: 4170722. DOI: 10.1093/hmg/ddu328. View

5.
Voight B, Scott L, Steinthorsdottir V, Morris A, Dina C, Welch R . Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42(7):579-89. PMC: 3080658. DOI: 10.1038/ng.609. View